Summary
Severe, debilitating nausea and vomiting are seen in almost 100% of patients treated with cis-platinum. These side-effects can be so severe and prolonged as to preclude therapy in a large number of patients. Commonly used antiemetics have had only limited success in controlling cis-platinum-induced nausea and vomiting. Various reports have indicated benefits from steroids in this setting.
We have tested a high-dose dexamethasone regimen with or without neuroleptics, which inhibits chemotherapy-induced vomiting in 50% of patients failing with prior antiemetics and in 71% of those who had not received prior antiemetics. This treatment was administered on an out-patient basis as it involved oral administration of the antiemetic.
Neuroleptic therapy was not randomly assigned, but the results of this pilot study suggest that it did not enhance dexamethasone's efficacy. There were no significant side-effects due to the steroids. The antiemetic effectiveness of dexamethasone was retained through repeated courses of chemotherapy.
Similar content being viewed by others
References
Baker JJ, Lokey JL, Price NA, Winokur SH, Bowen J, Taylor A (1979) Letter. N Engl J Med 301: 728
Bhakoo HS, Paolini NS, Milholland RJ, Lopez RE, Rosen F (1981) Glucocorticoid receptors and the effect of glucocorticoids on the growth of B-16 melanoma. Cancer Res 41: 1695–1701
Chang AE, Shiling DJ, Stillman RC, Goldberg NH, Seipp CA, Barofsky C, Simon RM, Rosenberg SA (1979) Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate; a prospective randomized evaluation. Ann Intern Med 91: 819–824
Drapkin R, McAloon E, Sokol G, Paladine W, Marks R (1981) The antiemetic effect of dexamethasone in patients receiving cis-platinum. Proc ASCO 22: 340
Einhorn LH, Williams SD (1979) The role of cis-platinum in solid-tumor therapy. N Engl J Med 300: 289–291
Ekert H, Waters KD, Jurk IH, Mobilia J, Loughnan P (1979) Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. Med J Aust 2: 657–659
Frytak S, Moertel CG, O'Fallon JR, Rubin J, Creagan ET, O'Connell MJ, Schutt AJ, Schwartao NW (1979) Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy: A comparison with prochlorperazine and a placebo. Ann Intern Med 91: 825–830
Frytak S, Moertel CG, Eagan RT, O'Fallon JR (1981) A double-blind comparison of metoclopramide and prochloperazine as antiemetics for platinum therapy. Proc ASCO 22: 350
Gralla RJ, Squillante A, Itri LM, Pisko S, Kelsen DP, Young CW (1981) High-dose metoclopramide: Effective antiemetic against cis-platin in randomized trials vs placebo and prochlorperazine. Proc ASCO 22: 344
Grossman B, Lessin LS, Cohen P (1980) Droperidol prevents nausea and vomiting from cis-platinum. N Engl J Med 301: 47
Gylys JA, Doran KM, Buyniski JP (1979) Antagonism of cis-platin induced emesis in the dog. Res Commun Chem Pathol Pharmacol 23: 61–68
Haid M (1981) Steroid antiemetics may be harmful. N Engl J Med 304: 1237
Herman TS, Einhorn LH, Jones SE, Magy C, Chester AB, Dean JC, Furnas B, Williams SD, Leigh SA, Dorr RT, Moon TE (1979) Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 300: 1295–1297
Kahn T, Elias EG, Mason GR (1978) A single dose of metloclopramide in the control of vomiting from cis-dichloro-diammineplatinum (II) in man. Cancer Treat Rep 62: 1106–1107
Lee BJ (1981) Methylprednisolone as an antiemetic. N Engl J Med 304: 486
Levitt M, Wilson A, Bowman D, Faiman C, Kemel S, Krepart G, Schipper H, Weinerman B, Weinerman R (1981) Dose vs response of tetrahydrocannabinol vs prochlorperazine as chemotherapy antiemetics. Proc ASCO 22: 352
Loeser EA, Bennett G, Stanley TH, Machin R (1979) Comparison of droperidol, haloperidol, and prochlorperazine as postoperative antiemetics. Can Anaesth Soc J 26: 125–127
Moertel CG, Reitemeier RJ (1969) Controlled clinical studies of orally administered drugs. Gastroenterology 57: 262–268
Neidhardt J, Gagen M, Metz E (1980) Haldol is an effective antiemetic for platinum- and mustard-induced vomiting when other agents fail. Proc ASCO 21: 365
Orr LE, McKernan JF, Bloome B (1980) Antiemetic effect of tetrahydrocannabinol, compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. Arch Intern Med 140: 1431–1433
Plotkin DA, Plotkin D, Okum R (1973) Haloperidol in the treatment of nausea and vomiting due to cytotoxic drug administration. Curr Ther Res 15: 599–602
Rich WM, Abdulhayoglu G, DiSaia PJ (1980) Methylprednisolone as an antiemetic during cancer chemotherapy — a pilot study. Gynecol Oncol 9: 193–198
Robins IH, Ershler WB, DeJongh L, Chang YC, Drozdowicz PM, Carr BI, Meyer DK (1979) Antiemetic effect of intravenous diazepam in patients receiving cis-diamminedi-chloroplatinum II. A pilot study. Pediatr Oncol 27: 247–249
Rosenberg B (1975) Possible mechanisms for the antitumor activity of platinum coordination complexes. Cancer Chem Rep [1] 69: 589–598
Sallan SE, Cronin C, Zelen M, Zinberg NE (1980) Antiemetics in patients receiving chemotherapy for cancer, a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med 302: 135–138
Strum SB, Opfell RW, McDermed JE, Reich LP (1981) Intravenous metoclopramide (MCP) inhibition of cis-platinum (DDP) induced nausea and vomiting. Proc ASCO 22: 231
Stryker JA, Demers LM, Mortel R (1979) Prophylactic ibuprofen administration during pelvic irradiation. Int J Radiat Oncol Biol Phys 5: 2049–2052
Tornetta FJ (1972) Double-blind evaluation of haloperidol for antiemetic activity. Anesth Analg (Cleve) 51: 964–967
Tornetta FJ (1977) A comparison of droperidol, diazepam, and hydroxyzine hydrochloride as premedication. Anesth Analg (Cleve) 56: 496–500
Wilson T, Weltz M, Molimando D, Perry D, Baldwin P, Kimball D (1981) Continuous infusion of droperidol: antiemetic therapy for cis-platinum toxicity. Proc ASCO 22: 351
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aapro, M.S., Alberts, D.S. High-dose dexamethasone for prevention of cis-platin-induced vomiting. Cancer Chemother. Pharmacol. 7, 11–14 (1981). https://doi.org/10.1007/BF00258206
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00258206